
Overview
Brent Rexer is an Oncologist in Nashville, Tennessee. Dr. Rexer is rated as an Experienced provider by MediFind in Gastrostomy. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Gastrostomy. Dr. Rexer is currently accepting new patients.
His clinical research consists of co-authoring 25 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3601 The Vanderbilt Clinic, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Vanderbilt Health Clinicians, LLC
Michael Gibson is an Oncologist in Nashville, Tennessee. Dr. Gibson is rated as a Distinguished provider by MediFind in Gastrostomy. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Adenoid Cystic Carcinoma, Percutaneous Coronary Intervention (PCI), and Gastrostomy. Dr. Gibson is currently accepting new patients.
Vanderbilt Health Clinicians, LLC
Kristen Ciombor is an Oncologist and a Hematologist in Nashville, Tennessee. Dr. Ciombor is rated as a Distinguished provider by MediFind in Gastrostomy. Her top areas of expertise are Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, Colonoscopy, and Gastrostomy. Dr. Ciombor is currently accepting new patients.
Paul Cha is a Hematologist Oncology specialist and a Hematologist in Clarksville, Tennessee. Dr. Cha is rated as an Experienced provider by MediFind in Gastrostomy. His top areas of expertise are Liver Failure, Subacute Combined Degeneration, Glossitis, Colonoscopy, and Gastrostomy. Dr. Cha is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Rexer isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Rexer isDistinguished. Learn about Breast Cancer.
- Breast Cancer in MenDr. Rexer isDistinguished. Learn about Breast Cancer in Men.
- HER-2 Positive Breast CancerDr. Rexer isDistinguished. Learn about HER-2 Positive Breast Cancer.
- Inflammatory Breast CancerDr. Rexer isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Rexer isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- AgranulocytosisDr. Rexer isExperienced. Learn about Agranulocytosis.
- GastrostomyDr. Rexer isExperienced. Learn about Gastrostomy.
- Triple-Negative Breast CancerDr. Rexer isExperienced. Learn about Triple-Negative Breast Cancer.